Which statements describe a Type I dose–receptor curve?

Which statements describe a Type I dose–receptor curve?

• A. X-axis is Drug Dosage; Y-axis is Response; curve can be hyperbolic or sigmoidal.
• B. X-axis is Receptor Occupancy; Y-axis is Drug Dosage; curve is linear.
• C. X-axis is Time; Y-axis is Dose; curve is exponential.
• D. X-axis is Dose; Y-axis is Time; curve is logarithmic.

Answer: (A)

The key idea is how a drug’s dose translates into the pharmacologic effect when receptors mediate the response. In a Type I dose–receptor curve, you plot the drug dose (or concentration) on the x-axis and the observed effect or response on the y-axis. As the dose increases, more receptors are engaged and the response rises, but it saturates because there are only so many receptors to occupy, producing a plateau. Depending on receptor binding and signaling, the curve can be hyperbolic (simple occupancy) or become sigmoidal when there’s cooperativity or amplification in the downstream response. Why this fits best: the relationship described uses dose on the x-axis and response on the y-axis, reflecting how increasing dose drives response up to a maximum. The curve’s possible hyperbolic or sigmoidal shapes align with receptor occupancy and downstream signaling dynamics. Why the other descriptions don’t fit: plots that place receptor occupancy on the x-axis or swap dose and time, or those that claim a linear, exponential, or logarithmic relationship, don’t capture the standard saturable, receptor-mediated relationship between dose and effect that defines this curve type.

The key idea is how a drug’s dose translates into the pharmacologic effect when receptors mediate the response. In a Type I dose–receptor curve, you plot the drug dose (or concentration) on the x-axis and the observed effect or response on the y-axis. As the dose increases, more receptors are engaged and the response rises, but it saturates because there are only so many receptors to occupy, producing a plateau. Depending on receptor binding and signaling, the curve can be hyperbolic (simple occupancy) or become sigmoidal when there’s cooperativity or amplification in the downstream response.

Why this fits best: the relationship described uses dose on the x-axis and response on the y-axis, reflecting how increasing dose drives response up to a maximum. The curve’s possible hyperbolic or sigmoidal shapes align with receptor occupancy and downstream signaling dynamics.

Why the other descriptions don’t fit: plots that place receptor occupancy on the x-axis or swap dose and time, or those that claim a linear, exponential, or logarithmic relationship, don’t capture the standard saturable, receptor-mediated relationship between dose and effect that defines this curve type.